Barclays PLC increased its stake in shares of Hancock Whitney Co. (NASDAQ:HWC – Free Report) by 149.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 321,196 shares of the company’s stock after purchasing an additional 192,295 shares during the period. Barclays PLC owned approximately 0.37% of Hancock Whitney worth $16,435,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Versor Investments LP acquired a new stake in shares of Hancock Whitney in the 3rd quarter valued at about $844,000. Quest Partners LLC grew its holdings in shares of Hancock Whitney by 66.7% during the 3rd quarter. Quest Partners LLC now owns 33,106 shares of the company’s stock worth $1,694,000 after purchasing an additional 13,243 shares in the last quarter. GSA Capital Partners LLP bought a new position in shares of Hancock Whitney in the 3rd quarter valued at $2,605,000. Texas Permanent School Fund Corp increased its holdings in shares of Hancock Whitney by 35.4% during the second quarter. Texas Permanent School Fund Corp now owns 102,103 shares of the company’s stock worth $4,884,000 after buying an additional 26,705 shares in the last quarter. Finally, Cornercap Investment Counsel Inc. acquired a new position in shares of Hancock Whitney during the third quarter worth $508,000. Institutional investors own 81.22% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts have weighed in on HWC shares. Truist Financial decreased their price target on Hancock Whitney from $57.00 to $56.00 and set a “hold” rating for the company in a report on Friday, September 20th. DA Davidson boosted their target price on shares of Hancock Whitney from $62.00 to $65.00 and gave the stock a “buy” rating in a research report on Wednesday, October 16th. Stephens upgraded Hancock Whitney from an “equal weight” rating to an “overweight” rating in a research note on Monday, December 9th. Finally, Keefe, Bruyette & Woods lifted their target price on shares of Hancock Whitney from $60.00 to $70.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 4th. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, Hancock Whitney currently has a consensus rating of “Moderate Buy” and an average price target of $58.00.
Hancock Whitney Trading Up 0.2 %
Shares of NASDAQ HWC opened at $57.78 on Friday. The stock has a market cap of $4.97 billion, a P/E ratio of 12.96 and a beta of 1.27. The company has a debt-to-equity ratio of 0.06, a current ratio of 0.82 and a quick ratio of 0.81. Hancock Whitney Co. has a 1 year low of $41.19 and a 1 year high of $62.40. The firm has a 50-day moving average of $55.94 and a 200 day moving average of $51.73.
Hancock Whitney (NASDAQ:HWC – Get Free Report) last released its quarterly earnings data on Tuesday, October 15th. The company reported $1.33 earnings per share for the quarter, beating analysts’ consensus estimates of $1.31 by $0.02. The business had revenue of $525.37 million during the quarter, compared to analyst estimates of $363.54 million. Hancock Whitney had a net margin of 19.30% and a return on equity of 11.47%. During the same period last year, the business earned $1.12 EPS. As a group, sell-side analysts expect that Hancock Whitney Co. will post 5.19 EPS for the current fiscal year.
Hancock Whitney Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Thursday, December 5th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, December 5th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.77%. Hancock Whitney’s dividend payout ratio is currently 35.87%.
Insider Transactions at Hancock Whitney
In other Hancock Whitney news, Director Christine L. Pickering sold 763 shares of the company’s stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $52.40, for a total value of $39,981.20. Following the completion of the transaction, the director now directly owns 23,518 shares in the company, valued at $1,232,343.20. This represents a 3.14 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO John M. Hairston sold 18,000 shares of Hancock Whitney stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $59.44, for a total transaction of $1,069,920.00. Following the completion of the sale, the chief executive officer now owns 254,026 shares in the company, valued at approximately $15,099,305.44. This represents a 6.62 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 27,994 shares of company stock worth $1,593,710 in the last quarter. Company insiders own 1.10% of the company’s stock.
About Hancock Whitney
Hancock Whitney Corporation operates as the financial holding company for Hancock Whitney Bank that provides traditional and online banking services to commercial, small business, and retail customers. It offers various transaction and savings deposit products consisting of brokered deposits, time deposits, and money market accounts; treasury management services, secured and unsecured loan products including revolving credit facilities, and letters of credit and similar financial guarantees; and trust and investment management services to retirement plans, corporations, and individuals, and investment advisory and brokerage products.
Featured Articles
- Five stocks we like better than Hancock Whitney
- The Risks of Owning Bonds
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Earnings Per Share Calculator: How to Calculate EPS
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 3 Small Caps With Big Return Potential
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Hancock Whitney Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hancock Whitney and related companies with MarketBeat.com's FREE daily email newsletter.